Abstract

BackgroundComorbid anxiety disorders are extremely prevalent in bipolar disorder (BD) and have substantial impact on the course of illness. Limited evidence regarding treatment factors has led to a renewal of research efforts examining both the impact of treatments on comorbid anxiety and the impact of comorbid anxiety on treatments. The current study examines the impact of comorbid anxiety disorders on response to two psychosocial interventions for BD.MethodsA sample of 204 patients with BD took part in the study. Of them, 41.7% had a comorbid anxiety disorder. All participants received either individual cognitive-behavioral therapy or group psychoeducation for BD. Evaluations included complete pretreatment and 18-month follow-up assessments of mood and anxiety symptoms, functioning, medication compliance, dysfunctional attitudes, and coping style. Outcome was compared based on the presence or absence of a comorbid anxiety disorder.Results and discussionThe participants with comorbid anxiety disorders ranked more severe than those without on several measures. Despite more severe illness characteristics, the magnitude of their treatment gains was equivalent or superior to that of the participants without anxiety disorders on a variety of outcome measures. Although the treatments did not specifically target the anxiety disorder, the participants made significant improvements in anxiety symptoms. Despite greater illness severity, patients with comorbid anxiety disorders can make substantial gains from psychosocial interventions targeting BD. Even in the presence of an anxiety disorder, they are able to attend to the content of the psychosocial treatments and apply it to better manage their condition. The presence of a comorbid anxiety disorder should not be considered a deterrent to offering BD-focused psychosocial treatments.

Highlights

  • Comorbid anxiety disorders are extremely prevalent in bipolar disorder (BD) and have substantial impact on the course of illness

  • There was no significant difference in age (t(202) = 0.018, p = 0.99), sex (χ2(1) = 2.814, p = 0.09), marital status (χ2(2) = 2.975, p = 0.23), and primary diagnosis (BD-I vs. BD-II; χ2(1) = 1.058, p = 0.30) based on the presence of a comorbid anxiety disorder

  • Significant anxiety disorder effects show that the participants with comorbid anxiety disorders ranked significantly more severely on HAMDDepression and both measures of anxiety symptoms

Read more

Summary

Introduction

Comorbid anxiety disorders are extremely prevalent in bipolar disorder (BD) and have substantial impact on the course of illness. Comorbid anxiety disorders are associated with more affective relapses, increased suicidality, sleep disturbances, decreased work and social functioning, and increased barriers to effective treatment (Hawke et al 2013; Freeman et al 2002). They appear to reduce the effectiveness of mood stabilizers (Keller 2006) and increase nonadherence to pharmacotherapy (Perlis et al 2010), substantially complicating the pharmacological treatment approach (Schaffer et al 2012)

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call